Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Recent advances in metal-organic frameworks for therapeutic applications in periodontitis

Chen J., Bai Y., Ding Y., Wang L., Zhang W., Yang F.

Narrative Review on Chronic Inflammation, Immune Modulation, published in Front Med (Lausanne) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Med (Lausanne) (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41333792
PMCID
PMC12667246
DOI
10.3389/fmed.2025.1706849
Citations
2

Abstract (original English)

Periodontitis is a highly prevalent chronic inflammatory disease that leads to the destruction of periodontal tissues and has systemic health implications. Current treatments, such as mechanical debridement and antibiotics, are often inadequate due to poor biofilm penetration, drug resistance, and limited regenerative capacity. Metal-organic frameworks (MOFs) have recently emerged as a transformative platform to address these limitations and surpass traditional nanomaterials (e.g., liposomes, dendrimers). Their tunable porosity, multifunctional composition, and responsive degradation enable antibacterial, anti-inflammatory, and pro-regenerative actions. This review highlights the mechanisms by which MOFs combat periodontal pathogens, resolve inflammation, and promote tissue regeneration, outperforming conventional materials. We also discuss combinatorial strategies, such as photodynamic and immunomodulatory therapies, that enhance treatment efficacy. Despite promising preclinical results, challenges in biocompatibility, biodegradation, and clinical translation remain. Future efforts should focus on developing intelligent, multifunctional MOF platforms capable of microenvironment-responsive therapy to achieve complete periodontal restoration.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research